10-Q: DSwiss, Inc. Reports Strong Revenue Growth in Q1 2025, Despite Net Profit Decline
Quarterly Report (Form 10-Q)
DSwiss, Inc. saw a significant increase in revenue for the three months ended March 31, 2025, but experienced a decrease in net profit compared to the same period in the previous year.
Summary
- DSwiss, Inc. reported its financial results for the quarter ended March 31, 2025.
- The company's revenue increased to $1,001,186 from $471,377 in the same period last year.
- Gross profit was $263,047, slightly lower than the $269,885 reported in Q1 2024.
- Net income decreased to $138,736 from $177,665 year-over-year.
- The company's cash and cash equivalents totaled $304,637 as of March 31, 2025.
- Net cash used in operating activities was $84,751, compared to net cash generated of $62,517 in the prior year.
- The company identified material weaknesses in its internal control over financial reporting.
Sentiment
Score: 5
Explanation: The document presents mixed signals. Revenue growth is positive, but declining profits and identified internal control weaknesses temper the outlook. The company's reliance on future financing adds uncertainty.
Positives
- The company experienced a substantial increase in revenue, more than doubling year-over-year.
- The company is expanding its client base in OEM/ODM services.
- DSwiss has a strong relationship with new retail tech companies.
- The company plans to expand globally through strategic partnerships.
Negatives
- Net profit decreased compared to the same period last year.
- The company experienced negative operating cash flow.
- Material weaknesses were identified in internal control over financial reporting.
- Gross profit was slightly lower than the same period last year due to higher cost of revenue.
Risks
- The company's ability to continue as a going concern is dependent on improving profitability and financial support from shareholders.
- The company has material weaknesses in internal control over financial reporting.
- Fluctuations in exchange rates could impact the company's income.
- The company is exposed to credit risk related to accounts receivable.
- The company relies on social media marketing, which could be affected by changes in social media platforms or user behavior.
Future Outlook
The company expects its current capital resources to meet its basic operating requirements for approximately twelve months and plans to grow through social media marketing and strategic partnerships.
Management Comments
- Management believes the existing shareholders or external financing will provide the additional cash to meet the Company's obligations as they become due.
- The feedback we have received from our clients has been overwhelmingly positive, which has helped us to create a robust brand image.
Industry Context
The company operates in the biotech-nutraceutical, beauty supplies, and medical consumables industries, focusing on OEM/ODM services. The company is expanding its client base in OEM/ODM services and has developed products and Business-to-business (B2B) DNA genotyping private label services that exceed the clients expectation.
Comparison to Industry Standards
- It is difficult to compare DSwiss directly to industry standards without knowing specific competitors and their financial results.
- However, the company's focus on OEM/ODM services is a common strategy in the nutraceutical and skincare industries.
- Many companies in these sectors also utilize social media marketing to reach customers and build brand awareness.
- The company's emphasis on certifications and approvals from the Ministry of Health (MOH) Malaysia aligns with industry best practices for ensuring product quality and safety.
Related Party Transactions
- Professional fees paid to a related party A totaled $4,292 for the period ended March 31, 2025.
- Sales to a related party B amounted to $1,284 for the period ended March 31, 2025.
Stakeholder Impact
- Shareholders may be concerned about the decline in net profit and the identified material weaknesses in internal control.
- Employees may be affected by potential changes in operations or financial stability.
- Customers may be impacted by the company's ability to maintain product quality and availability.
- Suppliers may be affected by the company's financial performance and ability to meet its obligations.
- Creditors may be concerned about the company's negative operating cash flow and reliance on future financing.
Next Steps
- The company plans to implement its social media marketing strategy.
- The company intends to form partnerships with local companies in various countries to expand globally.
- The company needs to address the identified material weaknesses in internal control over financial reporting.
Key Dates
| Date | Description |
|---|---|
| 2011-03-10 | DSwiss Sdn Bhd incorporated in Malaysia |
| 2015-05-28 | DSwiss, Inc. incorporated in Nevada |
| 2015-05-28 | DSwiss Holding Limited incorporated in Seychelles |
| 2016-03-17 | DSwiss Biotech Sdn Bhd incorporated in Malaysia |
| 2016-07-20 | Date of Form S-1 Amendment No.8 |
| 2018-07-30 | FASB issued ASU 2018-11 |
| 2018-07-31 | First finance lease agreement commenced |
| 2019-01-01 | DSwiss officially adopted ASC 842 |
| 2019-11-01 | Effective date of ASC 842, Leases |
| 2020 | Expanded client base in OEM/ODM services |
| 2021-12-03 | Second finance lease agreement commenced |
| 2022-12-31 | Date mentioned in relation to financial statements |
| 2023-01-17 | Date mentioned in relation to DSwiss Biotech Sdn Bhd Member DQWS:DSwissHKLimitedMember |
| 2023-01-18 | DSwiss (HK) Limited acquired 60% equity interest in DSwiss Biotech Sdn. Bhd. |
| 2023-12-31 | Balance as of December 31, 2023 (audited) |
| 2023-12 | FASB issued ASU 2023-09 |
| 2023-11 | FASB issued ASU 2023-07 |
| 2024-01-01 | Start of comparative period for financial results |
| 2024-03-31 | End of comparative period for financial results |
| 2024-11 | FASB issued ASU 2024-03 |
| 2024-12-21 | Third finance lease agreement commenced |
| 2024-12-31 | Year ended December 31, 2024 |
| 2025-01-01 | Start of current reporting period |
| 2025-01 | FASB clarified the effective date in January 2025 with the issuance of ASU 2025-01 |
| 2025-01-02 | DSwiss Sdn Bhd entered into a contract rental agreement |
| 2025-03-01 | Commencement date of office rental agreement |
| 2025-03-31 | End of current reporting period |
| 2025-05-15 | Date of report filing |
| 2025-06 | Due date of first finance lease agreement |
| 2025-11 | Due date of second finance lease agreement |
| 2026-12-15 | ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 |
| 2027-12-15 | ASU 2024-03 is effective for interim periods beginning after December 15, 2027 |
| 2029-11 | Due date of third finance lease agreement |
Keywords
financial results, biotech-nutraceutical, OEM/ODM, revenue, net income, DSwiss, financial statements
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.